Oscar Health Statistics
Total Valuation
Oscar Health has a market cap or net worth of $5.37 billion. The enterprise value is $3.06 billion.
Important Dates
The next confirmed earnings date is Wednesday, May 6, 2026, before market open.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Oscar Health has 297.43 million shares outstanding. The number of shares has decreased by -1.30% in one year.
| Current Share Class | 261.84M |
| Shares Outstanding | 297.43M |
| Shares Change (YoY) | -1.30% |
| Shares Change (QoQ) | +9.25% |
| Owned by Insiders (%) | 5.17% |
| Owned by Institutions (%) | 54.52% |
| Float | 242.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 21.52 |
| PS Ratio | 0.46 |
| Forward PS | 0.28 |
| PB Ratio | 5.23 |
| P/TBV Ratio | 5.45 |
| P/FCF Ratio | 5.04 |
| P/OCF Ratio | 4.87 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.26 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 2.89 |
Financial Position
The company has a current ratio of 0.95, with a Debt / Equity ratio of 0.51.
| Current Ratio | 0.95 |
| Quick Ratio | 0.92 |
| Debt / Equity | 0.51 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.47 |
| Interest Coverage | -22.52 |
Financial Efficiency
Return on equity (ROE) is -44.35% and return on invested capital (ROIC) is -24.40%.
| Return on Equity (ROE) | -44.35% |
| Return on Assets (ROA) | -4.44% |
| Return on Invested Capital (ROIC) | -24.40% |
| Return on Capital Employed (ROCE) | -27.10% |
| Weighted Average Cost of Capital (WACC) | 13.84% |
| Revenue Per Employee | $5.08M |
| Profits Per Employee | -$192,256 |
| Employee Count | 2,305 |
| Asset Turnover | 2.10 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Oscar Health has paid $5.61 million in taxes.
| Income Tax | 5.61M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +47.51% in the last 52 weeks. The beta is 1.93, so Oscar Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.93 |
| 52-Week Price Change | +47.51% |
| 50-Day Moving Average | 13.86 |
| 200-Day Moving Average | 15.88 |
| Relative Strength Index (RSI) | 78.63 |
| Average Volume (20 Days) | 6,005,979 |
Short Selling Information
The latest short interest is 26.16 million, so 8.80% of the outstanding shares have been sold short.
| Short Interest | 26.16M |
| Short Previous Month | 26.34M |
| Short % of Shares Out | 8.80% |
| Short % of Float | 10.77% |
| Short Ratio (days to cover) | 3.89 |
Income Statement
In the last 12 months, Oscar Health had revenue of $11.70 billion and -$443.15 million in losses. Loss per share was -$1.69.
| Revenue | 11.70B |
| Gross Profit | 1.68B |
| Operating Income | -396.36M |
| Pretax Income | -437.30M |
| Net Income | -443.15M |
| EBITDA | -367.47M |
| EBIT | -396.36M |
| Loss Per Share | -$1.69 |
Full Income StatementBalance Sheet
The company has $3.99 billion in cash and $498.80 million in debt, giving a net cash position of $2.28 billion or $7.65 per share.
| Cash & Cash Equivalents | 3.99B |
| Total Debt | 498.80M |
| Net Cash | 2.28B |
| Net Cash Per Share | $7.65 |
| Equity (Book Value) | 980.74M |
| Book Value Per Share | 3.29 |
| Working Capital | -249.18M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $1.09 billion and capital expenditures -$36.37 million, giving a free cash flow of $1.06 billion.
| Operating Cash Flow | 1.09B |
| Capital Expenditures | -36.37M |
| Depreciation & Amortization | n/a |
| Net Borrowing | 371.12M |
| Free Cash Flow | 1.06B |
| FCF Per Share | $3.56 |
Full Cash Flow StatementMargins
Gross margin is 14.38%, with operating and profit margins of -3.39% and -3.79%.
| Gross Margin | 14.38% |
| Operating Margin | -3.39% |
| Pretax Margin | -3.74% |
| Profit Margin | -3.79% |
| EBITDA Margin | -3.14% |
| EBIT Margin | -3.39% |
| FCF Margin | 9.05% |